These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 3020700

  • 21. Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimens.
    Lowenbraun S, Birch R, Buchanan R, Krauss S, Durant J, Perez C, Mill W, Vollmer R, Ogden L.
    Cancer; 1984 Dec 01; 54(11):2344-50. PubMed ID: 6093979
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Initial therapy with cisplatin plus VP-16 in small-cell lung cancer.
    Einhorn LH.
    Semin Oncol; 1986 Sep 01; 13(3 Suppl 3):5-9. PubMed ID: 3020701
    [Abstract] [Full Text] [Related]

  • 24. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
    Shepherd FA, Evans WK, MacCormick R, Feld R, Yau JC.
    Cancer Treat Rep; 1987 Oct 01; 71(10):941-4. PubMed ID: 2820571
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
    Furuse K, Fukuoka M, Nishiwaki Y, Kurita Y, Watanabe K, Noda K, Ariyoshi Y, Tamura T, Saijo N.
    J Clin Oncol; 1998 Jun 01; 16(6):2126-32. PubMed ID: 9626212
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Chemotherapy of small cell lung cancer].
    Komiya T, Takada M.
    Gan To Kagaku Ryoho; 1996 Aug 01; 23(9):1116-23. PubMed ID: 8751797
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A, Fusco V, Pennucci C, Baldini E, Orsatti M, Vitale V, Bonavia M, Baracco F, Mereu C, Rosso R.
    Anticancer Res; 1991 Aug 01; 11(2):681-4. PubMed ID: 1648333
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.
    Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, Goddard K, Fairey R, Voss N.
    J Clin Oncol; 1991 Sep 01; 9(9):1632-8. PubMed ID: 1651995
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Second-line oral chemotherapy (lomustine, cyclophosphamide, etoposide) versus intravenous therapy (cyclophosphamide, doxorubicin, and vincristine) in patients with relapsed small cell lung cancer: a randomized phase II study of GFPC 0501.
    Gervais R, Le Caer H, Monnet I, Falchero L, Baize N, Olivero G, Thomas P, Berard H, Auliac JB, Chouaid C, Groupe Français de Pneumo-Cancérologie 0501 Team.
    Clin Lung Cancer; 2015 Mar 01; 16(2):100-5. PubMed ID: 25467927
    [Abstract] [Full Text] [Related]

  • 40. Improvement of long-term survival in extensive small-cell lung cancer.
    Jackson DV, Case LD, Zekan PJ, Powell BL, Caldwell RD, Bearden JD, Nelson EC, Muss HB, Cooper MR, Richards F.
    J Clin Oncol; 1988 Jul 01; 6(7):1161-9. PubMed ID: 2839632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.